Send the following on WhatsApp
Continue to Chat新冠疫苗新選擇?Sanofi 與 GSK 共同開發的重組蛋白疫苗第 3 期試驗表現正面,盼盡快獲核准 https://geneonline.news/sanofi-gsk-covid19-vaccine-phase-3-booster-dose/
新冠疫苗新選擇?Sanofi 與 GSK 共同開發的重組蛋白疫苗第 3 期試驗表現正面,盼盡快獲核准 https://geneonline.news/sanofi-gsk-covid19-vaccine-phase-3-booster-dose/